Efficacy and safety of rectal 5-aminosalicylic acid versus corticosteroids in active distal ulcerative colitis: a systematic review and network meta-analysis-Reference-Cited by-同舟云学术

Efficacy and safety of rectal 5-aminosalicylic acid versus corticosteroids in active distal ulcerative colitis: a systematic review and network meta-analysis

Published:2017-04-25 Issue:1 Volume:7 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Zhao Xiaojing,Zhou Changcheng,Ma Jingjing,Zhu Yunjuan,Sun Min,Wang Peixue,Zhang Yi,Ma Haiqin,Zhang Hongjie

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/srep46693.pdf

Reference52 articles.

1. Regueiro, M. D. Diagnosis and treatment of ulcerative proctitis. J Clin Gastroenterol 38, 733–40 (2004).

2. Ordás, I., Eckmann, L., Talamini, M., Baumgart, D. C. & Sandborn, W. J. Ulcerative colitis. Lancet 380, 1606–19 (2012).

3. Ayres, R. C., Gillen, C. D., Walmsley, R. S. & Allan, R. N. Progression of ulcerative proctosigmoiditis: incidence and factors influencing progression. Eur J Gastroenterol Hepatol 8, 555–8 (1996).

4. Henriksen, M. et al. Ulcerative colitis and clinical course: results of a 5-year population-based follow-up study (the IBSEN study). Inflamm Bowel Dis 12, 543–50 (2006).

5. Truelove, S. C. & Witts, L. J. Cortisone in ulcerative colitis; final report on a therapeutic trial. Br Med J 2, 1041–8 (1955).

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Colon-targeted delivery systems of budesonide as second-line therapy in inflammatory bowel disease;Journal of Drug Delivery Science and Technology;2024-03

2. Novel Budesonide Suppository and Standard Budesonide Rectal Foam Induce High Rates of Clinical Remission and Mucosal Healing in Active Ulcerative Proctitis: a Randomised, Controlled, Non-inferiority Trial;Journal of Crohn's and Colitis;2022-06-16

3. Tonifying-Qi-and-Detoxification Decoction attenuated injuries of colon and lung tissues in ulcerative colitis rat model via regulating NF-κB and p38MAPK pathway;Annals of Translational Medicine;2022-04

4. Modelling the benefits of an optimised treatment strategy for 5-ASA in mild-to-moderate ulcerative colitis;BMJ Open Gastroenterology;2022-02

5. Lentinan-Based Oral Nanoparticle Loaded Budesonide With Macrophage-Targeting Ability for Treatment of Ulcerative Colitis;Frontiers in Bioengineering and Biotechnology;2021-08-27